1. Home
  2. Pharma & Healthcare
  3. Global Endocannabinoid System Targeted Therapeutics Market Status and Forecast 2021-2027

Global Endocannabinoid System Targeted Therapeutics Market Status and Forecast 2021-2027

Publication Month: Sep 2021 | No. of Pages: 118 Published By: GRD Survey
Single User License: US $ 2980
Corporate User License: US $ 5960

This report provides a comprehensive analysis of current global Endocannabinoid System Targeted Therapeutics market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Endocannabinoid System Targeted Therapeutics industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Endocannabinoid System Targeted Therapeutics market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Endocannabinoid System Targeted Therapeutics Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Endocannabinoid System Targeted Therapeutics market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Endocannabinoid System Targeted Therapeutics Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Endocannabinoid System Targeted Therapeutics industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Oral
Inhalation
Others

Segmented by Application
Autoimmune Disorders
Genetic Disorders
Neurological Disorders
Pain Disorders

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Zelira Therapeutics
Tilray
Therapix Biosciences
Pure Green
MAKScientific
GW Pharmaceuticals
GB Sciences
Corbus Pharmaceuticals
Botanix Pharmaceuticals
Avicanna


Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Endocannabinoid System Targeted Therapeutics Market Status and Forecast (2016-2027)
1.3.2 Global Endocannabinoid System Targeted Therapeutics Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Endocannabinoid System Targeted Therapeutics Supply by Company
2.1 Global Endocannabinoid System Targeted Therapeutics Sales Value by Company
2.2 Endocannabinoid System Targeted Therapeutics Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Endocannabinoid System Targeted Therapeutics Market Status by Type
3.1 Endocannabinoid System Targeted Therapeutics Type Introduction
3.1.1 Oral
3.1.2 Inhalation
3.1.3 Others
3.2 Global Endocannabinoid System Targeted Therapeutics Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Endocannabinoid System Targeted Therapeutics Market Status by Application
4.1 Endocannabinoid System Targeted Therapeutics Segment by Application
4.1.1 Autoimmune Disorders
4.1.2 Genetic Disorders
4.1.3 Neurological Disorders
4.1.4 Pain Disorders
4.2 Global Endocannabinoid System Targeted Therapeutics Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Endocannabinoid System Targeted Therapeutics Market Status by Region
5.1 Global Endocannabinoid System Targeted Therapeutics Market by Region
5.2 North America Endocannabinoid System Targeted Therapeutics Market Status
5.3 Europe Endocannabinoid System Targeted Therapeutics Market Status
5.4 Asia Pacific Endocannabinoid System Targeted Therapeutics Market Status
5.5 Central & South America Endocannabinoid System Targeted Therapeutics Market Status
5.6 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Status
6 North America Endocannabinoid System Targeted Therapeutics Market Status
6.1 North America Endocannabinoid System Targeted Therapeutics Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Endocannabinoid System Targeted Therapeutics Market Status
7.1 Europe Endocannabinoid System Targeted Therapeutics Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Endocannabinoid System Targeted Therapeutics Market Status
8.1 Asia Pacific Endocannabinoid System Targeted Therapeutics Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Endocannabinoid System Targeted Therapeutics Market Status
9.1 Central & South America Endocannabinoid System Targeted Therapeutics Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Status
10.1 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Endocannabinoid System Targeted Therapeutics Market Forecast by Type and by Application
12.1 Global Endocannabinoid System Targeted Therapeutics Sales Value Forecast (2022-2027)
12.2 Global Endocannabinoid System Targeted Therapeutics Forecast by Type
12.3 Global Endocannabinoid System Targeted Therapeutics Forecast by Application
13 Global Endocannabinoid System Targeted Therapeutics Market Forecast by Region/Country
13.1 Global Endocannabinoid System Targeted Therapeutics Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Zelira Therapeutics
14.1.1 Company Information
14.1.2 Endocannabinoid System Targeted Therapeutics Product Introduction
14.1.3 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Tilray
14.2.1 Company Information
14.2.2 Endocannabinoid System Targeted Therapeutics Product Introduction
14.2.3 Tilray Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Therapix Biosciences
14.3.1 Company Information
14.3.2 Endocannabinoid System Targeted Therapeutics Product Introduction
14.3.3 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Pure Green
14.4.1 Company Information
14.4.2 Endocannabinoid System Targeted Therapeutics Product Introduction
14.4.3 Pure Green Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 MAKScientific
14.5.1 Company Information
14.5.2 Endocannabinoid System Targeted Therapeutics Product Introduction
14.5.3 MAKScientific Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 GW Pharmaceuticals
14.6.1 Company Information
14.6.2 Endocannabinoid System Targeted Therapeutics Product Introduction
14.6.3 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 GB Sciences
14.7.1 Company Information
14.7.2 Endocannabinoid System Targeted Therapeutics Product Introduction
14.7.3 GB Sciences Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 Corbus Pharmaceuticals
14.8.1 Company Information
14.8.2 Endocannabinoid System Targeted Therapeutics Product Introduction
14.8.3 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 Botanix Pharmaceuticals
14.9.1 Company Information
14.9.2 Endocannabinoid System Targeted Therapeutics Product Introduction
14.9.3 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 Avicanna
14.10.1 Company Information
14.10.2 Endocannabinoid System Targeted Therapeutics Product Introduction
14.10.3 Avicanna Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
14.10.4 SWOT Analysis
15 Conclusion
16 Methodology

Tables and Figures

List of Tables

Table Global Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Company (2019-2021)
Table Global Endocannabinoid System Targeted Therapeutics Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Endocannabinoid System Targeted Therapeutics Sales Area
Table Endocannabinoid System Targeted Therapeutics Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Type (2016-2021)
Table Global Endocannabinoid System Targeted Therapeutics Sals Value Market Share by Type (2016-2021)
Table North America Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Type (2016-2021)
Table North America Endocannabinoid System Targeted Therapeutics Sales Value Market Share by Type (2016-2021)
Table Europe Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Type (2016-2021)
Table Europe Endocannabinoid System Targeted Therapeutics Sales Value Market Share by Type (2016-2021)
Table Asia Pacific Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific Endocannabinoid System Targeted Therapeutics Sales Value Market Share by Type (2016-2021)
Table Central & South America Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific Endocannabinoid System Targeted Therapeutics Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa Endocannabinoid System Targeted Therapeutics Sales Value Market Share by Type (2016-2021)
Table Global Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Application (2016-2021)
Table Global Endocannabinoid System Targeted Therapeutics Value Market Share by Application (2016-2021)
Table North America Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Application (2016-2021)
Table North America Endocannabinoid System Targeted Therapeutics Sales Value Market Share by Application (2016-2021)
Table Europe Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Application (2016-2021)
Table Europe Endocannabinoid System Targeted Therapeutics Sales Value Market Share by Application (2016-2021)
Table Asia Pacific Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific Endocannabinoid System Targeted Therapeutics Sales Value Market Share by Application (2016-2021)
Table Central & South America Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific Endocannabinoid System Targeted Therapeutics Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa Endocannabinoid System Targeted Therapeutics Sales Value Market Share by Application (2016-2021)
Table Global Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Region (2016-2021)
Table Global Endocannabinoid System Targeted Therapeutics Value Market Share by Region (2016-2021)
Table North America Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Country (2016-2021)
Table North America Endocannabinoid System Targeted Therapeutics Value Market Share by Country (2016-2021)
Table Europe Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Country (2016-2021)
Table Europe Endocannabinoid System Targeted Therapeutics Value Market Share by Country (2016-2021)
Table Asia Pacific Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Endocannabinoid System Targeted Therapeutics Value Market Share by Country (2016-2021)
Table Central & South America Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Endocannabinoid System Targeted Therapeutics Value Market Share by Country (2016-2021)
Table Middle East & Africa Endocannabinoid System Targeted Therapeutics Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Endocannabinoid System Targeted Therapeutics Value Market Share by Country (2016-2021)
Table Global Endocannabinoid System Targeted Therapeutics Value (Million USD) Forecast by Type (2022-2027)
Table Global Endocannabinoid System Targeted Therapeutics Value Market Share Forecast by Type (2022-2027)
Table Global Endocannabinoid System Targeted Therapeutics Value (Million USD) Forecast by Application (2022-2027)
Table Global Endocannabinoid System Targeted Therapeutics Value Market Share Forecast by Application (2022-2027)
Table Global Endocannabinoid System Targeted Therapeutics Value (Million USD) Forecast by Region (2022-2027)
Table Global Endocannabinoid System Targeted Therapeutics Value Market Share Forecast by Region (2022-2027)
Table Zelira Therapeutics Company Information
Table Zelira Therapeutics Product Introduction
Table Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
Table Tilray Company Information
Table Tilray Product Introduction
Table Tilray Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
Table Therapix Biosciences Company Information
Table Therapix Biosciences Product Introduction
Table Therapix Biosciences Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
Table Pure Green Company Information
Table Pure Green Product Introduction
Table Pure Green Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
Table MAKScientific Company Information
Table MAKScientific Product Introduction
Table MAKScientific Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
Table GW Pharmaceuticals Company Information
Table GW Pharmaceuticals Product Introduction
Table GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
Table GB Sciences Company Information
Table GB Sciences Product Introduction
Table GB Sciences Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
Table Corbus Pharmaceuticals Company Information
Table Corbus Pharmaceuticals Product Introduction
Table Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
Table Botanix Pharmaceuticals Company Information
Table Botanix Pharmaceuticals Product Introduction
Table Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
Table Avicanna Company Information
Table Avicanna Product Introduction
Table Avicanna Endocannabinoid System Targeted Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets